Longitude Capital Partners IV, LLC's Net Worth

$0

Estimate Recalculated Nov 1, 2024 06:27AM EST

Who is Longitude Capital Partners IV, LLC?

Longitude Capital Partners IV, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Lexeo Therapeutics, Inc., Vera Therapeutics, Inc., and Eargo, Inc..

SEC CIK

Longitude Capital Partners IV, LLC's CIK is 0001829169

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Lexeo Therapeutics, Inc. (LXEO) Snapshot price: $10.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.57M
$11.00
—
2.57M
Nov 7
Form 3
—
0
—
—
0
No matching records found

Eargo, Inc. (EAR) No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-25.39%
-994.99K
—
—
2.92M
Scheduled
Apr 14
Form 4
∞
3.92M
$18.00
—
3.92M
Oct 20
No matching records found

Vera Therapeutics, Inc. (VERA) Snapshot price: $37.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.71M
$7.00
$11,999,995.00
1.71M
Feb 6
Form 4
+10.76%
333.33K
$15.00
$4,999,995.00
3.43M
Feb 10
Form 4
∞
3.1M
$11.00
—
3.1M
May 18
Form 3
—
0
—
—
0
No matching records found